Scientific poster: Development of a robust and scalable hiPSC platform for the identification of efficacious and less toxic ASOs
Scientific poster: Evaluation of hiPSC-derived neurons and microglia as in vitro model for neuroinflammation
Assessing cardiotoxicity of a highly selective novel MCL1 inhibitor with iPSC-derived models
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
